FWP
NVAX icon

FAS Wealth Partners’s Novavax NVAX Stock Holding History

FAS Wealth Partners’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-660
Closed -$7K – 195
2019
Q1 		$7K Buy
660
+10
+2% +$316 ﹤0.01% 190
2018
Q4 		$24K Sell
650
-1
-0.2% -$39 0.01% 188
2018
Q3 		$24K Hold
651
– – 0.01% 177
2018
Q2 		$17K Buy
651
+50
+8% +$1.69K ﹤0.01% 170
2018
Q1 		$25K Buy
+601
New +$24.1K 0.01% 170

Other funds holding NVAX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

FAS Wealth Partners's NVAX Position: Q2 2019 in Review

FAS Wealth Partners sold out of Novavax (NVAX) in Q2 2019, closing a stake of 660 shares — an estimated $7K sold.

FAS Wealth Partners first reported a position in NVAX in Q1 2018 and held it in 5 quarters. The position peaked at $25K in Q1 2018. 81 funds tracked by Wall St. Rank hold NVAX as of Q2 2019.

  • FAS Wealth Partners reported no remaining Novavax position as of Q2 2019 after selling out during the quarter.
  • FAS Wealth Partners sold 660 Novavax shares in Q2 2019, an estimated $7K.
  • FAS Wealth Partners first reported a position in Novavax in Q1 2018 and held it in 5 quarters.
  • FAS Wealth Partners's Novavax position peaked at $25K in Q1 2018.
  • 81 funds tracked by Wall St. Rank held Novavax as of Q2 2019.

Based on FAS Wealth Partners's 13F filing for Q2 2019, filed 25 Jul 2019.